PVI
RVNC

Pura Vida Investments’s Revance Therapeutics, Inc. RVNC Stock Holding History

Pura Vida Investments’s Portfolio RVNC Stock Details RVNC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-40,900
Closed -$999K – 181
2020
Q2 		$999K Buy
+40,900
New +$807K 0.1% 105
2017
Q4 		– Sell
-50,000
Closed -$1.38M – 100
2017
Q3 		$1.38M Buy
+50,000
New +$1.21M 0.4% 62

Other funds holding RVNC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Pura Vida Investments's RVNC Position: Q3 2020 in Review

Pura Vida Investments sold out of Revance Therapeutics, Inc. (RVNC) in Q3 2020, closing a stake of 40,900 shares — an estimated $999K sold.

Pura Vida Investments first reported a position in RVNC in Q3 2017 and held it in 2 quarters. The position peaked at $1.38M in Q3 2017. 153 funds tracked by Wall St. Rank hold RVNC as of Q3 2020.

  • Pura Vida Investments reported no remaining Revance Therapeutics, Inc. position as of Q3 2020 after selling out during the quarter.
  • Pura Vida Investments sold 40,900 Revance Therapeutics, Inc. shares in Q3 2020, an estimated $999K.
  • Pura Vida Investments first reported a position in Revance Therapeutics, Inc. in Q3 2017 and held it in 2 quarters.
  • Pura Vida Investments's Revance Therapeutics, Inc. position peaked at $1.38M in Q3 2017.
  • 153 funds tracked by Wall St. Rank held Revance Therapeutics, Inc. as of Q3 2020.

Based on Pura Vida Investments's 13F filing for Q3 2020, filed 16 Nov 2020.